ACR Incidental Pancreatic Cyst

management

Management pathway for incidentally detected pancreatic cysts based on size and worrisome features.

vigenteAmerican College of Radiology2017CT, MRI

Aplicar o ACR Incidental Pancreatic Cyst a um achado

Descreva o achado como no laudo. A resposta aponta uma das categorias publicadas, com a probabilidade e o trecho que a decide.

O texto não é armazenado. Remova nomes, documentos e contatos.

Categorias

Reescritas a partir da fonte e citadas
small-cyst
1 de 5

Small cyst

Incidental pancreatic cyst <1.5 cm in an asymptomatic adult. Chart 1 separates age <65 from age 65-79; a T2-hyperintense 'white dot' <5 mm is a special subgroup. Worrisome features, high-risk stigmata or related symptoms supersede routine size surveillance.

CondutaFor age <65, reimage yearly five times, then every 2 years twice if stable, stopping after at least 9 stable years. For age 65-79, reimage every 2 years five times and stop after 10 stable years. After significant growth while still <1.5 cm, reimage yearly or consider EUS/FNA; if size reaches >=1.5 cm, move to Chart 2 or EUS/FNA. For a <5 mm white-dot lesion, one CT or MRI at 2 years is enough to stop if stable. Surveillance generally ends at age 80.
RiscoMost small presumed mucinous cysts are expected to be indolent, but the paper states that accurate malignant-transformation rates for small incidental cysts are unknown. Size alone is not a calibrated individual risk estimate.
verificadoManagement of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings CommitteeMegibow et al., JACR 2017, Fig. 1/Chart 1 and legend; pp.6-9 length of follow-up, reporting, applicability and Chart 1 explanation.
intermediate-cyst
2 de 5

Intermediate size cyst

Incidental pancreatic cyst 1.5-2.5 cm in an asymptomatic adult. Chart 2A applies when cyst-main-pancreatic-duct communication is established; Chart 2B applies when communication is absent or cannot be determined. Worrisome features or high-risk stigmata trigger the escalation pathway regardless of the routine schedule.

CondutaWith MPD communication, a 1.5-1.9 cm cyst is reimaged yearly for 5 years then every 2 years twice; a 2.0-2.5 cm cyst is reimaged every 6 months four times, yearly twice, then every 2 years three times. EUS/FNA at detection is an alternative. Without or with unknown MPD communication, either use EUS/FNA or reimage every 6 months four times, yearly twice, then every 2 years three times. Growth to >2.5 cm prompts EUS/FNA; result-dependent paths distinguish SCA/cPNET/pseudocyst from mucinous or indeterminate aspiration.
RiscoThe 1.5-2.5 cm band has no single malignancy percentage. Risk assessment depends on duct communication, growth, mural or wall findings, duct caliber, symptoms and sampling rather than size alone.
verificadoManagement of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings CommitteeMegibow et al., JACR 2017, Fig. 2/Charts 2A-2B and legends; pp.9-10 Chart 2 explanation and follow-up horizon.
large-cyst
3 de 5

Large cyst

Incidental pancreatic cyst >2.5 cm. Chart 3 separates a diagnosed serous cystadenoma, low-risk imaging, high-risk imaging and direct EUS/FNA. Low-risk imaging means no mural nodule, no wall thickening, normal-caliber MPD and no peripheral calcification; high-risk imaging includes the converse features, with the standardized worrisome/high-risk definitions assessed separately.

CondutaFor low-risk imaging, reimage every 6 months four times, then yearly twice and every 2 years three times, stopping after 10 stable years. High-risk imaging prompts EUS/FNA plus surgical consultation. A symptomatic SCA or SCA >4 cm merits surgical consultation; any cyst should undergo EUS/FNA before contemplated resection. For a patient >=80 at presentation, use the separate 2.5 cm Chart 4, generally reimaging a low-risk lesion every 2 years twice and pursuing EUS/FNA only when health, preferences and surgical candidacy support it.
RiscoA >2.5 cm cyst receives closer evaluation, but this size branch is not a numeric malignancy probability. High-grade dysplasia or malignancy can occur below 3 cm, which is why the ACR chose 2.5 cm for this management chart.
verificadoManagement of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings CommitteeMegibow et al., JACR 2017, Fig. 3/Chart 3 and Fig. 4/Chart 4 with legends; pp.9-10 Chart 3-4 explanations.
worrisome-features
4 de 5

Worrisome features present

ACR 2017 worrisome features are cyst >=3 cm, thickened or enhancing cyst wall, nonenhancing mural nodule, or MPD caliber >=7 mm. High-risk stigmata are obstructive jaundice with a pancreatic-head cyst, an enhancing solid component or enhancing mural nodule, or MPD >=10 mm without obstruction.

CondutaA worrisome feature or high-risk stigma prompts EUS with FNA and surgical consultation. The stated exception is size >=3 cm as the only worrisome feature: if no other worrisome feature or high-risk stigma is present, imaging follow-up is an alternative. New symptoms terminate the incidental-cyst algorithm and require clinical evaluation.
RiscoThese are qualitative escalation features rather than calibrated malignancy probabilities. An enhancing component, obstructive jaundice or MPD >=10 mm carries the stronger high-risk-stigma label; cyst size >=3 cm alone has an explicit surveillance alternative.
verificadoManagement of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings CommitteeMegibow et al., JACR 2017, Table 1; pp.7-9 reporting consideration 4, applicability and common principle 4; Charts 1-4 escalation footnotes.
main-duct-involvement
5 de 5

Main pancreatic duct involvement

Cyst-MPD communication and/or main pancreatic duct dilation. Communication establishes a branch-duct or combined IPMN pattern; record the widest MPD diameter even away from the cyst. MPD >=7 mm is a worrisome feature and MPD >=10 mm without obstruction is a high-risk stigma.

CondutaUse CT with 3D reconstructions or MRI/MRCP to assess communication. In a 1.5-2.5 cm cyst, confirmed communication selects Chart 2A; absent or indeterminate communication selects Chart 2B. Dilated MPD prompts EUS/FNA and surgical evaluation according to the 7 mm and 10 mm escalation thresholds rather than routine surveillance alone.
RiscoThe paper cites disease-level malignancy rates of 38%-65% for combined-form and 38%-68% for main-duct IPMN, but those cohort ranges are not an individual risk estimate for every cyst with duct communication or dilation.
verificadoManagement of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings CommitteeMegibow et al., JACR 2017, pp.4-5 clinical-importance histology context; pp.7-8 reporting consideration 3 and Table 1; Fig. 2/Charts 2A-2B.
Lógica de decisão estruturada

Return one primary size branch plus any applicable duct or worrisome-feature flags. Preserve age, growth, MPD communication and surgical candidacy; do not turn this consensus flowchart into an automatic procedure order.

{
  "applicability": {
    "use_for": "Incidentally detected pancreatic cyst in an asymptomatic adult (age >=18 years).",
    "stop_algorithm_when": [
      "jaundice",
      "anorexia_or_weight_loss",
      "palpable_mass",
      "steatorrhea",
      "relevant_abnormal_laboratory_value_such_as_elevated_amylase",
      "pain_attributable_to_the_cyst",
      "new_related_symptoms_during_surveillance"
    ],
    "surgical_candidacy_rule": "Do not pursue surveillance in a patient who is not a surgical candidate; incorporate overall health and preferences.",
    "default_histology_assumption": "Presume mucinous unless definitive imaging or aspiration establishes another histology."
  },
  "categories": [
    {
      "outcome_code": "small-cyst",
      "role": "primary_size_branch",
      "size": "<1.5_cm"
    },
    {
      "outcome_code": "intermediate-cyst",
      "role": "primary_size_branch",
      "size": "1.5_to_2.5_cm"
    },
    {
      "outcome_code": "large-cyst",
      "role": "primary_size_branch",
      "size": ">2.5_cm"
    },
    {
      "outcome_code": "worrisome-features",
      "role": "escalation_flag",
      "coexistence": "emit_alongside_the_size_branch_when_present"
    },
    {
      "outcome_code": "main-duct-involvement",
      "role": "duct_flag_and_branch_selector",
      "coexistence": "emit_alongside_the_size_branch_when_present"
    }
  ],
  "reporting_requirements": [
    "cyst_morphology_and_location",
    "single_long_axis_size_with_series_and_image_number",
    "possible_MPD_communication",
    "worrisome_features_and_high_risk_stigmata",
    "growth",
    "multiplicity_and_index_lesion"
  ],
  "growth_definition": [
    {
      "initial_size": "<5_mm",
      "significant_growth": "100_percent_increase_in_long_axis"
    },
    {
      "initial_size": ">=5_mm_and_<15_mm",
      "significant_growth": "50_percent_increase_in_long_axis"
    },
    {
      "initial_size": ">=15_mm",
      "significant_growth": "20_percent_increase_in_long_axis"
    },
    {
      "growth_rate": ">2_mm_per_year",
      "interpretation": "rapid_growth_feature"
    }
  ],
  "escalation_features": {
    "worrisome_features": [
      "cyst_>=3_cm",
      "thickened_or_enhancing_wall",
      "nonenhancing_mural_nodule",
      "MPD_>=7_mm"
    ],
    "high_risk_stigmata": [
      "obstructive_jaundice_with_cyst_in_pancreatic_head",
      "enhancing_solid_component_or_enhancing_mural_nodule",
      "MPD_>=10_mm_without_obstruction"
    ],
    "action": "EUS_with_FNA_and_surgical_consultation",
    "size_only_exception": "A cyst >=3 cm with no other worrisome feature or high-risk stigma may alternatively be followed.",
    "output_codes": [
      "worrisome-features",
      "main-duct-involvement"
    ]
  },
  "size_branches": {
    "small_cyst": {
      "outcome_code": "small-cyst",
      "size": "<1.5_cm",
      "age_<65": {
        "initial": "reimage_every_1_year_x5",
        "if_stable": "reimage_every_2_years_x2",
        "stop": "if_stable_for_minimum_9_years"
      },
      "age_65_to_79": {
        "initial": "reimage_every_2_years_x5",
        "stop": "if_stable_for_10_years"
      },
      "white_dot_<5_mm": "one_CT_or_MRI_at_2_years_then_stop_if_stable",
      "after_growth_still_<1.5_cm": "reimage_every_1_year_or_consider_EUS_FNA",
      "after_growth_>=1.5_cm": "move_to_intermediate_chart_or_EUS_FNA"
    },
    "intermediate_cyst_with_MPD_communication": {
      "outcome_codes": [
        "intermediate-cyst",
        "main-duct-involvement"
      ],
      "size": "1.5_to_2.5_cm",
      "size_1.5_to_1.9_cm": {
        "schedule": "reimage_every_1_year_x5_then_every_2_years_x2",
        "stop": "if_stable_for_9_years"
      },
      "size_2.0_to_2.5_cm": {
        "schedule": "reimage_every_6_months_x4_then_every_1_year_x2_then_every_2_years_x3",
        "stop": "if_stable_for_10_years"
      },
      "alternative_at_detection": "EUS_FNA",
      "growth_to_>2.5_cm": "EUS_FNA"
    },
    "intermediate_cyst_without_or_unknown_MPD_communication": {
      "outcome_code": "intermediate-cyst",
      "size": "1.5_to_2.5_cm",
      "imaging_path": {
        "schedule": "reimage_every_6_months_x4_then_every_1_year_x2_then_every_2_years_x3",
        "stop": "if_stable_for_10_years"
      },
      "alternative_path": "EUS_FNA_to_classify_mucinous_status_and_guide_management",
      "after_growth_still_<=2.5_cm": "reimage_every_6_months_x2_then_every_1_year_x5_then_every_2_years_or_EUS_FNA",
      "after_growth_>2.5_cm": "EUS_FNA",
      "after_EUS_FNA": {
        "SCA_cPNET_or_pseudocyst": "management_depends_on_diagnosis",
        "mucinous_or_indeterminate": "reimage_every_6_months_x4_then_every_1_year_x2_then_every_2_years_x3",
        "growth": "surgical_consultation"
      }
    },
    "large_cyst": {
      "outcome_code": "large-cyst",
      "size": ">2.5_cm",
      "SCA": "If >4 cm or symptomatic, surgical consultation for possible resection; otherwise diagnosis-specific management.",
      "low_risk_by_imaging": {
        "features": [
          "no_mural_nodule",
          "no_wall_thickening",
          "normal_caliber_MPD",
          "no_peripheral_calcification"
        ],
        "schedule": "reimage_every_6_months_x4_then_every_1_year_x2_then_every_2_years_x3",
        "stop": "if_stable_for_10_years"
      },
      "high_risk_by_imaging": {
        "features": [
          "mural_nodule",
          "wall_thickening",
          "MPD_>=7_mm",
          "peripheral_calcification"
        ],
        "action": "EUS_FNA_plus_surgical_consultation"
      },
      "alternative_at_detection": "EUS_FNA",
      "pre_resection": "EUS_FNA_is_advised_before_resection_to_reduce_unnecessary_surgery"
    },
    "age_>=80_at_presentation": {
      "principle": "Base workup on overall health, preferences and surgical candidacy.",
      "cyst_<=2.5_cm": {
        "schedule": "reimage_every_2_years_x2",
        "stop": "if_stable",
        "after_growth_still_<=2.5_cm": "reimage_every_1_year_then_stop_if_stabilized_or_no_longer_surgical_candidate",
        "after_growth_>2.5_cm": "EUS_FNA"
      },
      "cyst_>2.5_cm_low_risk": {
        "schedule": "reimage_every_2_years_x2",
        "stop": "if_stable",
        "growth": "EUS_FNA_plus_surgical_consultation"
      },
      "cyst_>2.5_cm_high_risk": "EUS_FNA_plus_surgical_consultation_if_surgical_candidate"
    }
  },
  "duct_logic": {
    "communication": "CT_with_3D_reconstructions_or_MRI_MRCP_can_establish cyst-MPD communication and a branch-duct or combined IPMN pattern.",
    "record": "Report the widest MPD diameter even when it is away from the cyst.",
    "thresholds": [
      {
        "finding": "MPD_>=7_mm",
        "outcome_code": "main-duct-involvement",
        "level": "worrisome"
      },
      {
        "finding": "MPD_>=10_mm_without_obstruction",
        "outcome_code": "main-duct-involvement",
        "level": "high_risk_stigma"
      }
    ]
  },
  "multiplicity": "Use the largest cyst as the index lesion but assess every cyst for growth, worrisome features and high-risk stigmata.",
  "follow_up_horizon": "Generally 9-10 years and stop at age 80; when a patient approaches 80, transition case-by-case to the age-80 chart rather than restarting a new surveillance clock.",
  "missing_input_behavior": [
    "Do not recommend a surveillance interval until age, exact size, symptoms, surgical candidacy and worrisome/high-risk features are known.",
    "For a 1.5-2.5 cm cyst, report whether MPD communication is present, absent or cannot be determined; do not assume it.",
    "When prior imaging is unavailable, state that growth cannot be assessed rather than labeling the cyst stable."
  ],
  "version_context": {
    "implemented_system": "ACR Incidental Findings Committee pancreatic cyst white paper, 2017",
    "current_adjacent_document": "Current ACR Appropriateness Criteria Pancreatic Cyst topic continues to cite the 2017 white paper for incidental-cyst management.",
    "rule": "Keep the 2017 flowchart version explicit and do not silently merge Fukuoka or another society's thresholds into it."
  },
  "source_locator": "Megibow et al., JACR 2017;14:911-923: Figs. 1-4 (Charts 1, 2A, 2B, 3 and 4), Table 1, pp.7-10 reporting, applicability, common principles and chart explanations. ACR Appropriateness Criteria Pancreatic Cyst reviewed for current version context."
}

Referência, não é dispositivo médico. Confira a publicação primária vigente. O radiologista que assina o laudo continua autor e responsável.